Scripps Raises 2026 Political Ad Revenue Guide to $275M, Completes Workforce Cuts
Read source articleWhat happened
Scripps raised its full-year 2026 Local Media political advertising revenue guidance to approximately $275 million, about 40% above the 2022 midterm cycle. This upward revision indicates a stronger-than-expected political ad environment, which is critical for the company's cash generation given its high debt load. Separately, Scripps completed its planned 2026 workforce reductions, adding to the over $40 million in annual savings from earlier restructuring actions. While these developments support the company's deleveraging efforts, core advertising remains structurally weak amid secular shifts to digital and CTV. Investors should also weigh the ongoing strategic uncertainty, including Sinclair's unsolicited bid and the impending expiry of the poison pill in November 2026.
Implication
Investors should view the raised political guide as a positive but not transformational. It increases the probability of achieving the base case of net leverage near 4.0-4.3x by end of 2026. However, the company still faces high interest costs and weak non-election cash flows. The workforce cuts may protect margins but could impair content quality and local news competitiveness. The M&A overhang remains a key swing factor; if a credible bid emerges before pill expiry, upside could be significant, but family control and regulatory hurdles make a near-term deal unlikely. Overall, the news supports a slightly more constructive view but does not justify moving from WAIT to BUY at current levels.
Thesis delta
The previous thesis was WAIT, based on high leverage, fragile non-election cash generation, and an overemphasized M&A narrative. The new information slightly improves the earnings outlook for 2026 due to higher political revenue and completed cost reductions. However, it does not change the fundamental risks: core advertising erosion and balance sheet stress remain. Thus, the thesis delta is a modest positive shift within the WAIT stance, with a possibility of upgrading if deleveraging accelerates and M&A clarity emerges.
Confidence
medium